在肝硬化中对败血症的未来管理
Ayush Jain1, Srajit Singh1, Rakhi Maiwall1
1Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, 110070, India.
Journal of clinical and experimental hepatology
|November 11, 2025
概括
败血症的治疗已经有了显著的进化,特别是在肝脏疾病的重症患者中. 本综述涵盖了对败血症原因,生物标志物和治疗方法的新见解,包括人工智能和精准医学,以减少死亡率.
科学领域:
- 关键护理医学 关键护理医学
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
背景情况:
- 败血症是重症监护室的主要死亡原因,特别影响肝病患者.
- 最近的进展重新塑造了败血症的理解和治疗方法.
研究的目的:
- 审查在重症患者中不断变化的病理生理学和败血症的管理,重点是肝病.
- 突出新兴的生物标志物,人工智能和精准医学在败血症护理中.
主要方法:
- 关于近期败血症研究进展的文献综述.
- 综合有关败血症病理生理学和治疗策略的当前知识.
- 对特定器官的支持性护理和未来研究方向的讨论.
主要成果:
- 对败血症的理解已经转向了精细的定义和风险分层.
- 新兴的生物标志物和人工智能驱动的方法显示出改善败血症管理的希望.
- 特定器官的策略对于优化患者的治疗结果至关重要.
结论:
- 关于败血症病理生理学和新的治疗策略的持续学习是必不可少的.
- 整合人工智能和精准医学有可能减少与败血症相关的死亡率.
- 肝病学家和重症监护医生必须跟上这些发展,以获得有效的患者护理.
相关概念视频
01:28Esophageal Varices-II: Clinical Features and Management
355
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
355
01:28Pleural Effusion II: Symptoms and Management
623
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
623
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
208
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
208
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
171
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
171
01:24Liver Regeneration
4.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.2K